Global Markets
S&P 500 — US Large Cap Index
NASDAQ 100 — Tech Growth Index
Dow Jones — Industrial Average
FTSE 100 — UK Blue Chips
Euro Stoxx 50 — Eurozone Leaders
DAX 40 — German Equities
CAC 40 — French Market Index
Nikkei 225 — Japan Benchmark
Hang Seng — Hong Kong Index
Shanghai Composite — China Mainland
ASX 200 — Australian Market
TSX Composite — Canada Index
Nifty 50 — India Large Cap
STI Index — Singapore Market
KOSPI — South Korea Index
Bovespa — Brazil Equities
JSE Top 40 — South Africa Index
IPC Index — Mexico Market
S&P 500 — US Large Cap Index
NASDAQ 100 — Tech Growth Index
Dow Jones — Industrial Average
FTSE 100 — UK Blue Chips
Euro Stoxx 50 — Eurozone Leaders
DAX 40 — German Equities
CAC 40 — French Market Index
Nikkei 225 — Japan Benchmark
Hang Seng — Hong Kong Index
Shanghai Composite — China Mainland
ASX 200 — Australian Market
TSX Composite — Canada Index
Nifty 50 — India Large Cap
STI Index — Singapore Market
KOSPI — South Korea Index
Bovespa — Brazil Equities
JSE Top 40 — South Africa Index
IPC Index — Mexico Market
AED • EUR • GBP • USD IBANs   |   CROSS BORDER FX   |   LOCAL CURRENCIES   |   GLOBAL COVERAGE
MarketsOpinionStocksTechnical AnalysisWall Street

SpaceX Isn’t Giving Up – What Could Stop the buying pressure of Musk’s “Stellar” Company?

SpaceX shares (SPCX.US) continued their upward trend on Monday, retesting the recent local highs of 12 August. A sharp rebound from the $106 level and growing institutional involvement have enabled the market to successfully absorb the recent first tranche of share releases; however, the coming months may pose a more serious test for the company’s elevated valuations.

The company’s share price chart confirms strong upward momentum following the summer correction. The company’s shares are once again approaching a key resistance level of around USD 147. The return to steady gains is largely driven by reports of a significant inflow of capital from the market’s largest players. Source: xStation According to the latest regulatory filings, Harvard Management has taken a stake in SpaceX worth US$2.2 billion (approximately 12.94 million shares), which currently accounts for more than half of its disclosed US equity portfolio. Alongside Harvard, other institutional investors have also accumulated significant stakes, including Intesa Sanpaolo (approximately $966 million) and the University of California (approximately $1 billion). The current share price remains comfortably above the IPO price ($135), valuing the entire company at around $1.85 trillion.

The schedule for the expiry of lock-up periods for early shareholders remains a key factor determining the share price’s performance in the coming quarters. The market has already seen the first large tranche of shares released (up to 911.5 million). Contrary to the fears of some market participants, this event did not trigger supply pressure. On the contrary, it provided the backdrop for a dynamic rebound from support levels around US$106, recorded just before the expiry of the lock-up period. Source: Bloomberg Financial Lp However, analysts are raising questions about the market’s reaction to subsequent tranches. The table above sets out the schedule for upcoming releases, the largest of which – potentially involving up to 1.3 billion shares – will take place following the publication of the second financial report (around October).

Register a Revolut Business Account
```

Market Analysis & Disclaimer

The market information, analysis, commentary, forecasts and opinions contained in this publication are provided by Octalas Group Ltd on behalf of Today Markets and Currency Hedger using information and data obtained from sources believed to be reliable. However, Octalas Group Ltd, Today Markets and Currency Hedger do not warrant or guarantee the accuracy, completeness or timeliness of the information presented and accept no responsibility for any loss or damage arising from reliance upon information contained herein, to the extent permitted by applicable law.

Market forecasts, expectations and opinions are based on analysis of available information and a number of assumptions regarding economic, financial, political and market conditions. Such assumptions may prove to be incorrect, and actual market developments may differ materially from those described or anticipated.

Nothing contained in this publication constitutes investment advice, financial advice, a personal recommendation, an offer, solicitation or invitation to buy, sell or otherwise transact in any financial instrument or investment product. The information is provided for general informational and educational purposes only and does not take into account the investment objectives, financial situation, experience or particular circumstances of any individual reader.

Past performance is not indicative of future results. Financial markets, including foreign exchange, commodities, equities, derivatives and other financial instruments, involve risk and prices can move rapidly. Readers should conduct their own independent research and, where appropriate, obtain advice from an appropriately authorised financial professional before making any investment or trading decision.

Where this publication refers to Today Markets, it represents market news, research, analysis and commentary published for informational purposes. Where Currency Hedger is referenced, it represents commentary concerning foreign exchange, currency exposure, international payments and hedging-related topics. References to particular financial instruments, markets, companies, currencies or commodities should not be interpreted as a recommendation to transact in them.

Octalas Group Ltd, Today Markets and Currency Hedger may have commercial interests or relationships with businesses, financial-service providers, technology providers or other market participants mentioned in their publications. Where relevant, such relationships or interests may create potential conflicts of interest. Appropriate measures are intended to be taken to ensure that published analysis and commentary are presented objectively and that commercial considerations do not determine the substance of market analysis.

The views expressed in this publication are those of the author or contributors at the time of publication and may change without notice as market conditions develop. Readers should not assume that any information contained herein has been updated following publication.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button